Table 1. Age and sex of individuals attending a participating ACCESS clinic during the study period.
| Pre-DAA cohort—Attended a clinic | Post-DAA cohort—Attended | |
|---|---|---|
| Total* | 93,856 | 113,832 |
| Sex, n (%) | ||
| Female | 47,676 (50.8) | 58,850 (51.7) |
| Male | 44,957 (47.9) | 53,422 (46.9) |
| Other | 499 (0.5) | 938 (0.8) |
| Unknown/missing | 724 (0.8) | 622 (0.6) |
| Age^, n (%) | ||
| 18–19 | 2,242 (2.4) | 2,464 (2.2) |
| 20–29 | 20,885 (22.3) | 24,638 (21.6) |
| 30–39 | 23,574 (25.1) | 28,807 (25.3) |
| 40–49 | 17,678 (18.8) | 21,258 (18.7) |
| 50+ | 29,477 (31.4) | 36,665 (32.2) |
| Mean age | 43.0 | 43.4 |
| History of OST prescription# | 10,546 (11.2) | 11,061 (9.7) |
*51,562 individuals were had a visit during each period and were included in both cohorts
^Age at end of 2016 for the pre-DAA cohort and age at end of 2019 for the post-DAA cohort
# Any prescription of Methadone, Suboxone, Buprenorphine or Naltrexone since Jan 1st 2011.